Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Oncology|November 10, 2015
Overview: New Modality for Cancer TreatmentHiroyoshi Nishikawa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|February 12, 2024
Establishment of immune suppression by cancer cells in the tumor microenvironmentHiroyoshi Nishikawa
International Journal of Cancer|June 3, 2010
Regulatory T cells in tumor immunityHiroyoshi Nishikawa, Shimon Sakaguchi
Current Topics in Microbiology and Immunology|September 8, 2017
Regulatory T Cells: Molecular and Cellular Basis for ImmunoregulationYosuke Togashi, Hiroyoshi Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Regulatory T cells: A target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Journal for Immunotherapy of Cancer|July 31, 2021
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapiesHiroyoshi Nishikawa, Shohei Koyama
Current Opinion in Immunology|January 14, 2014
Regulatory T cells in cancer immunotherapyHiroyoshi Nishikawa, Shimon Sakaguchi
International Immunology|August 10, 2021
Engineering strategies for broad application of TCR-T- and CAR-T-cell therapiesKeisuke Watanabe, Hiroyoshi Nishikawa
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunityVitaly Kochin, Hiroyoshi Nishikawa
Annals of the New York Academy of Sciences|March 23, 2018
Regulatory T cells: a potential target in cancer immunotherapyKohei Shitara, Hiroyoshi Nishikawa
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Oncology|November 10, 2015
Overview: New Modality for Cancer TreatmentHiroyoshi Nishikawa
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|February 12, 2024
Establishment of immune suppression by cancer cells in the tumor microenvironmentHiroyoshi Nishikawa
International Journal of Cancer|June 3, 2010
Regulatory T cells in tumor immunityHiroyoshi Nishikawa, Shimon Sakaguchi
Current Topics in Microbiology and Immunology|September 8, 2017
Regulatory T Cells: Molecular and Cellular Basis for ImmunoregulationYosuke Togashi, Hiroyoshi Nishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Regulatory T cells: A target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Journal for Immunotherapy of Cancer|July 31, 2021
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapiesHiroyoshi Nishikawa, Shohei Koyama
Current Opinion in Immunology|January 14, 2014
Regulatory T cells in cancer immunotherapyHiroyoshi Nishikawa, Shimon Sakaguchi
International Immunology|August 10, 2021
Engineering strategies for broad application of TCR-T- and CAR-T-cell therapiesKeisuke Watanabe, Hiroyoshi Nishikawa
Nagoya Journal of Medical Science|April 10, 2019
＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunityVitaly Kochin, Hiroyoshi Nishikawa
Annals of the New York Academy of Sciences|March 23, 2018
Regulatory T cells: a potential target in cancer immunotherapyKohei Shitara, Hiroyoshi Nishikawa
Pageof 20